Mutual of America Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$291K Buy
9,046
+11
+0.1% +$407 ﹤0.01% 1217
2025
Q4
$380K Buy
9,035
+222
+3% +$8.95K ﹤0.01% 1132
2025
Q3
$303K Buy
+8,813
New +$253K ﹤0.01% 1185

Other funds holding VCYT

Mutual of America Capital Management's VCYT Position: Q1 2026 in Review

Mutual of America Capital Management increased its Veracyte (VCYT) stake by 0.12% in Q1 2026, buying an estimated $407 and bringing the position to 9,046 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #1217.

Mutual of America Capital Management first reported a position in VCYT in Q3 2025 and has held it in 3 quarters since. The position peaked at $380K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Mutual of America Capital Management held 9,046 shares of Veracyte worth $291K as of Q1 2026.
  • Mutual of America Capital Management bought 11 Veracyte shares in Q1 2026, an estimated $407.
  • Veracyte made up ﹤0.01% of Mutual of America Capital Management's portfolio in Q1 2026, its #1217 holding.
  • Mutual of America Capital Management first reported a position in Veracyte in Q3 2025 and has held it in 3 quarters since.
  • Mutual of America Capital Management's Veracyte position peaked at $380K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.